Back to Search
Start Over
Clover's COVID-19 Vaccine Candidate Administered as Heterologous Booster in Investigator-Led Phase 2 Clinical Trial
- Source :
- GlobeNewswire. November 25, 2021
- Publication Year :
- 2021
-
Abstract
- CHENGDU, China, Nov 25, 2021 (GLOBE NEWSWIRE via COMTEX) -- -- The Phase 2 trial will evaluate SCB-2019 (CpG 1018/Alum) as a booster dose in individuals previously vaccinated with CoronaVac [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- GlobeNewswire
- Publication Type :
- News
- Accession number :
- edsgcl.683794741